News and Events | Preventogen

Arch Grants class of 2021

Press release

St. Louis Based Biotech Start-up Prevent-Plus Recognized as a 2021 Arch Grants Recipient

Clinical study

New clinical data highlighting the clinical success and efficacy of Preventogen

Clinical article

A Closer Look At An Emerging Option To Reduce Post-Op Infections

Clinical article

Prevention is the key—75,000 infection-related deaths and $33 Billion in costs

Press release

Preventogen: One of the first FDA-cleared products shown to reliably kill urgent CDC threat Candida auris in a lab

Clinical article

Why Wound Care is Essential during the COVID-19 Crisis

TRAINING
Instructions for Use

Preventogen is a product of Prevent-Plus, LLC © 2023 Prevent-Plus, LLC. All rights reserved.

Privacy Policy | Privacy Settings | Cookie Policy | Terms of Service | Accessibility Statement

Preventogen is a FDA cleared Class I medical device. Preventogen is a non-antibiotic, microbicidal liquid polymer that forms a protective film barrier over the skin. WARNING: For use on minor wounds, cuts, abrasions, burns and scrapes that are clean and dry. Not for use on deep, infected, or puncture wounds. Do not use near eyes or mouth. For external use only. Please see complete Instructions for Use.